bupropion
- Product NDC
- 55700-644
- Requested package NDC
- 55700-644-30
- 11-digit product format
- 557000644
- Labeler code
- 55700
- Product ID
- 55700-644_f1fd4649-2377-4a7a-bfd4-e0afe18ae503
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Lake Erie Medical DBA Quality Care Products LLC
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2018-06-22
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55700-644 | 55700-644-30 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202304-001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | |
| A202304-002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | |
| A202304-003 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202304-001 | AB1 |
| A202304-002 | AB1 |
| A202304-003 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202304-001 | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202304-002 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202304-003 | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202304-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202304-002 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202304-003 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Major Pharmaceuticals | 67b6bcf8-0e7c-4e74-ad72-54f1bd6e65ad | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Cardinal Health 107, LLC | 439a7e93-f578-434f-943f-4b93c35450f5 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Solco Healthcare US LLC | 39b2d509-1281-4464-9cf1-a94bbc18b84b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 850ac56a-ba50-4e61-b1ee-805e17735b5c | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Northwind Health Company, LLC | ab6cd2ea-507c-35e5-e053-2a95a90ac5cb | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | DIRECT RX | 96d87edc-d12b-44b2-e053-2995a90a4e63 | 2025-01-22 | Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 7ded4fa6-e637-4d59-a1b1-286854d4fe3a | 2024-08-09 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Proficient Rx LP | 909204fc-ff55-43d9-b9ee-e607ef60965e | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55700-644-30 | EA - Each | 55700-644 | 0e2a0df8-e3cf-4174-a709-a4c76fcdf1d2 | 1 | 2018-08-13 |
| 55700-644-60 | EA - Each | 55700-644 | a3bfce78-f9f9-4154-985a-de229fc73407 | 1 | 2018-08-13 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55700-644-30 | 55700064430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-644-30) | 2018-06-22 | 0000-00-00 | No | No | Current |